🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 12 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/03/2025 38,24 39,70 37,63 38,66 +0,42% 5,41% 1.623.000
03/03/2025 40,81 42,51 37,20 38,50 +2,42% 13,01% 2.396.000
28/02/2025 35,97 37,66 35,97 37,59 +3,44% 4,70% 720.400
27/02/2025 36,04 37,21 35,95 36,34 +0,53% 3,50% 999.000
26/02/2025 35,48 36,25 34,81 36,15 +3,02% 4,06% 1.024.900
25/02/2025 36,04 36,82 33,70 35,09 -2,53% 8,66% 1.614.800
24/02/2025 38,75 38,92 35,86 36,00 -7,10% 7,90% 1.143.000
21/02/2025 39,60 39,90 38,44 38,75 +0,68% 3,70% 659.600
20/02/2025 38,41 39,07 37,83 38,49 -0,10% 3,23% 618.700
19/02/2025 37,82 38,65 37,50 38,53 +2,07% 3,03% 456.600
18/02/2025 38,50 39,10 37,64 37,75 -2,38% 3,81% 496.400
14/02/2025 38,74 39,37 38,36 38,67 -0,03% 2,61% 368.300
13/02/2025 37,62 38,72 37,38 38,68 +3,37% 3,56% 371.700
12/02/2025 36,43 37,54 36,34 37,42 +1,16% 3,29% 421.700
11/02/2025 37,77 38,01 36,70 36,99 -2,63% 3,47% 908.000
10/02/2025 39,05 39,52 37,74 37,99 -2,29% 4,56% 704.300
07/02/2025 37,81 39,66 37,81 38,88 +2,99% 4,89% 756.800
06/02/2025 38,36 39,31 37,70 37,75 -2,00% 4,20% 528.200
05/02/2025 37,72 38,62 37,72 38,52 +2,50% 2,39% 552.600
04/02/2025 37,55 38,32 37,06 37,58 +1,02% 3,36% 466.700
03/02/2025 37,08 37,50 36,65 37,20 -1,59% 2,29% 491.900
31/01/2025 38,92 39,64 37,58 37,80 -3,37% 5,29% 624.300
30/01/2025 38,70 39,45 37,98 39,12 +2,38% 3,80% 333.500
29/01/2025 37,67 38,85 37,67 38,21 +0,58% 3,12% 327.400
28/01/2025 38,44 39,23 37,91 37,99 -0,96% 3,43% 466.000
27/01/2025 37,73 39,89 37,51 38,36 +1,78% 6,31% 587.800
24/01/2025 37,58 38,70 37,00 37,69 -0,29% 4,52% 431.200
23/01/2025 36,79 37,94 36,72 37,80 +2,49% 3,32% 525.000
22/01/2025 38,06 38,47 36,56 36,88 -3,20% 5,02% 610.900
21/01/2025 37,18 38,50 37,18 38,10 +3,48% 3,55% 461.100